BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Xanthus Pharmaceuticals, Inc. Presents Phase 2 Data Showing Xanafide is Associated with Complete Remissions in Secondary AML

  June 4, 2007

   · 

  1 min read
• Drug Development

  INNOVIVE Pharmaceuticals Presents Additional Phase I Data on INNO-406 for Treatment of Gleevec-Resistant or Intolerant Chronic Myelogenous Leukemia at the American Society of Clinical Oncology Annual Meeting

  June 4, 2007

   · 

  1 min read
• Drug Development

  Abraxis BioScience, Inc.: ABRAXANE Demonstrates Longer Progression-Free Survival versus Taxotere in the Treatment of First-Line Metastatic Breast Cancer

  June 4, 2007

   · 

  1 min read
• Drug Development

  Hana Biosciences, Inc. Presents Data On Two Programs At the American Society of Clinical Oncology Annual Meeting

  June 4, 2007

   · 

  1 min read
• Drug Development

  PTC Therapeutics, Inc. Presents Phase 1 Results of its Novel VEGF Inhibitor, PTC299, at 43rd American Society of Clinical Oncology Annual Meeting

  June 4, 2007

   · 

  6 min read
• Drug Development

  Schering-Plough Corporation Release: CAELYX(R) Delays Time to Disease Progression as Maintenance Therapy in Patients with Metastatic Breast Cancer

  June 4, 2007

   · 

  6 min read
• Drug Development

  Lee Moffitt Cancer Center & Research Institute Release: Revlimid Data Presented at American Society of Clinical Oncology Demonstrates Impressive Survival Benefit and Stands to Change the Way Physicians Treat Multiple Myeloma

  June 4, 2007

   · 

  3 min read
• Drug Development

  Exelixis, Inc. Reports Comprehensive XL880 Phase I Data At American Society of Clinical Oncology

  June 4, 2007

   · 

  5 min read
• Drug Development

  Bristol-Myers Squibb Company Phase III Ixabepilone Study Demonstrated Significant Improvement in Progression-Free Survival in Patients With Advanced Metastatic Breast Cancer

  June 4, 2007

   · 

  4 min read
• Drug Development

  AEterna Zentaris Presents Detailed Phase 1 Results for Anti-Cancer Compound AEZS-108 at American Society of Clinical Oncology Meeting

  June 4, 2007

   · 

  6 min read